That is despite several European countries and Australia limiting its use because of safety concerns.
In Australia, the Pfizer vaccine is now the preferred option for people under 50, Britain is offering an alternative for those under 30 while France and Belgium recommend AstraZeneca be given to those 55 and over.
European regulators said earlier this month they had found a possible link between AstraZeneca's Covid-19 vaccine and a rare blood clotting problem that led to a small number of deaths.